The utility of multicenter cognitive test methodology and resultant outcomes of supplementation with docosahexaenoic acid in healthy 4-year-old children was evaluated in a randomized, placebo-controlled, double-blind study. Subjects received 400-mg/d docosahexaenoic acid (n = 85) or matching placebo (n = 90) in capsules for 4 months. Cognitive tests included the Leiter-R Test of Sustained Attention, Peabody Picture Vocabulary Test, Day-Night Stroop Test, and Conners' Kiddie Continuous Performance Test. The relationship of docosahexaenoic acid levels in capillary whole blood from a subsample (n = 93) with scores on cognitive tests was evaluated. For each test, results indicated that changes from baseline to end of treatment were not statistically significantly different between the docosahexaenoic acid group and the placebo group. Regression analysis, however, yielded a statistically significant positive (P = .018) association between the blood level of docosahexaenoic acid and higher scores on the Peabody Picture Vocabulary Test, a test of listening comprehension and vocabulary acquisition.
Burdge G.α-linolenic acid metabolism in men and women: nutritional and biological implication. Curr Opin Clin Nutr Care. 2004 ;7:137-144.
4.
Yuhas R., Pramuk K., Lien ELHuman milk fatty acid composition from nine countries varies most in DHA. Lipids. 2006;41:851-858.
5.
Ervin RB, Wright JD, Wang C-Y., Kennedy-Stephenson J.Dietary intake of fats and fatty acids for the United States population: 1999-2000 . Adv Data. 2004;Nov 8 (348):1-6.
6.
Eilander A., Hundscheid DC, Osendarp SJ, et al. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: A review of human studies. Prostag Leukotr Ess. 2007;76:189-203.
7.
Cohen JT, Bellinger DC, Connor WE, Shaywitz BAA quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am J Prev Med. 2005;29:366-374.
8.
Jensen CL, Voigt RG, Prager TC, et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr. 2005;82:125-132.
9.
Birch EE, Garfield S., Castañeda Y., Hughbanks-Wheaton D., Uauy R., Hoffman D.Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev. 2007;83:279-84.
10.
Bakker EC, Ghys AJ, Kester AD, et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur J Clin Nutr. 2003 ;57:89-95.
11.
Zhang J., Hebert JR, Muldoon MFDietary fat intake is associated with psychosocial and cognitive functioning of school-aged children in the United States. J Nutr. 2005;135:1967-1973.
12.
Richardson AJ, Puri BKA randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHDrelated symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:233-239.
13.
Richardson AJ, Montgomery P.The Oxford-Durham Study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005;115:1360-1366.
14.
Stevens L., Zhang W., Peck L., et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003 ;38:1007-1021.
15.
Voigt RG, Llorente AM, Jensen CLA randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/ hyperactivity disorder . J Pediatr. 2001;139:189-196.
16.
Hirayama S. , Hamazaki T., Terasawa K.Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study. Eur J Clin Nutr. 2004;58:467-473.
17.
National Center for Health Statistics.CDC Growth Charts: United States. Available at http://www.cdc.gov/growthcharts/. Accessed Nov 6, 2007.
18.
Bailey Hall E., Nelson E., Ryan AS, McCarthy D.Validation of a rapid measure of blood PUFA levels in humans. 98th AOCS Annual Meeting & Expo Abstracts. 2007:83
19.
Ichihara K. , Waku K., Yamaguchi C. et al. A convenient method for determination of the C 20-22 PUFA composition of glycerolipids in blood and breast milk . Lipids. 2002;37:523-526.
20.
Roid GH, Miller LJLeiter International Performance Scale-Revised. Wood Dale, IL: Stoelting Co, 1997.
21.
Dunn LM, Dunn LMPeabody Picture Vocabulary Test, Examiner's Manual. Circle Pines, MN: American Guidance Service, 1997.
22.
Gerstadt CL , Hong YJ, Diamond A.The relationship between cognition and action: performance of children 3½ - 7 years old on a Stroop-like day-night test. Cognition. 1994;53:129-153.
23.
Conners CKConners' Kiddie Continuous Performance Test (K-CPT). Computer Program for Windows™ Technical Guide and Software Material. North Tonawanda, NY: Multi-Health Systems, 2001.
24.
Wechsler D.Wechsler Intelligence Scale for Children-Revised. New York : The Psychological Corporation, 1974.
25.
Arterburn LM , Bailey Hall E., Oken H.Distribution, interconversion, and dose response of n-3 fatty acids. Am J Clin Nutr. 2006;83:1467S-1476S.
26.
Conquer JA, Holub BJDietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids. 1997;32:341-345.
27.
Jensen C., Voigt R., Llorente A., et al. Effect of maternal docosahexaenoic acid (DHA) supplementation on neuropsychological and visual status of former breast-fed infants at five years of age. Pediatr Res. 2004;55:1021A.
28.
Martinez M.Polyunsaturated fatty acids in the developing brain, red cells and plasma: influence on nutrition and peroxisomal disease . World Rev Nutr Diet. 1994;75:70-78.
29.
Yehuda S.Omega-6/omega-3 ratio and brain related functions. World Rev Nutr Diet. 2003;92:37-56.
30.
Thomas KMAssessing brain development using neuro-physiologic and behavioral measures . J Pediatr. 2003; 143:S46-S53.
